Your browser doesn't support javascript.
loading
Oscillatory underpinnings of mismatch negativity and their relationship with cognitive function in patients with schizophrenia.
Kaser, Muzaffer; Soltesz, Fruzsina; Lawrence, Phil; Miller, Sam; Dodds, Chris; Croft, Rodney; Dudas, Robert B; Zaman, Rashid; Fernandez-Egea, Emilio; Müller, Ulrich; Dean, Anna; Bullmore, Edward T; Nathan, Pradeep J.
Affiliation
  • Kaser M; Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom ; Bahcesehir University, Istanbul, Turkey ; Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, United Kingdom.
  • Soltesz F; GlaxoSmithKline, Clinical Unit Cambridge, Medicines Discovery and Development, Cambridge, United Kingdom.
  • Lawrence P; GlaxoSmithKline, Clinical Unit Cambridge, Medicines Discovery and Development, Cambridge, United Kingdom.
  • Miller S; GlaxoSmithKline, Clinical Unit Cambridge, Medicines Discovery and Development, Cambridge, United Kingdom.
  • Dodds C; GlaxoSmithKline, Clinical Unit Cambridge, Medicines Discovery and Development, Cambridge, United Kingdom.
  • Croft R; Department of Psychology, University of Wollongong, Wollongong, Australia.
  • Dudas RB; Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom ; Cambridge and Peterborough NHS Foundation Trust, United Kingdom.
  • Zaman R; Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom ; South Essex Partnership NHS Foundation Trust, United Kingdom.
  • Fernandez-Egea E; Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom ; Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, United Kingdom ; Cambridge and Peterborough NHS Foundation Trust, United Kingdom.
  • Müller U; Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom ; Cambridge and Peterborough NHS Foundation Trust, United Kingdom.
  • Dean A; Brain Mapping Unit, Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom.
  • Bullmore ET; Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, United Kingdom ; GlaxoSmithKline, Clinical Unit Cambridge, Medicines Discovery and Development, Cambridge, United Kingdom ; Cambridge and Peterborough NHS Foundation Trust, United Kingdom ; Brain Mapping Unit, Depar
  • Nathan PJ; Brain Mapping Unit, Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom ; School of Psychology and Psychiatry, Monash University, Melbourne, Australia ; Neuroscience Discovery Medicine, UCB Pharma, Brussels, Belgium.
PLoS One ; 8(12): e83255, 2013.
Article in En | MEDLINE | ID: mdl-24358266
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia / Schizophrenic Psychology / Brain / Cognition / Negativism Type of study: Clinical_trials Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2013 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia / Schizophrenic Psychology / Brain / Cognition / Negativism Type of study: Clinical_trials Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2013 Document type: Article Affiliation country: Country of publication: